A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Clinical trial NCT04814186 · COMPLETED
Trial details
- NCT number
- NCT04814186
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-22
- Primary completion
- 2023-10-16
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.